Stoke Therapeutics Stock Price Patterns
| STOK Stock | USD 34.37 3.39 10.94% |
Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.63) | EPS Estimate Current Year 0.0733 | EPS Estimate Next Year (3.11) | Wall Street Target Price 41.8889 | EPS Estimate Current Quarter (0.57) |
Using Stoke Therapeutics hype-based prediction, you can estimate the value of Stoke Therapeutics from the perspective of Stoke Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Stoke Therapeutics using Stoke Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Stoke using crowd psychology based on the activity and movement of Stoke Therapeutics' stock price.
Stoke Therapeutics Short Interest
An investor who is long Stoke Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Stoke Therapeutics and may potentially protect profits, hedge Stoke Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 21.9614 | Short Percent 0.2347 | Short Ratio 15.27 | Shares Short Prior Month 11.1 M | 50 Day MA 31.6208 |
Stoke Therapeutics Hype to Price Pattern
Investor biases related to Stoke Therapeutics' public news can be used to forecast risks associated with an investment in Stoke. The trend in average sentiment can be used to explain how an investor holding Stoke can time the market purely based on public headlines and social activities around Stoke Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Stoke Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Stoke Therapeutics.
Stoke Therapeutics Implied Volatility | 1.04 |
Stoke Therapeutics' implied volatility exposes the market's sentiment of Stoke Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Stoke Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Stoke Therapeutics stock will not fluctuate a lot when Stoke Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Stoke Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Stoke because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Stoke Therapeutics after-hype prediction price | USD 34.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Stoke contract
Based on the Rule 16, the options market is currently suggesting that Stoke Therapeutics will have an average daily up or down price movement of about 0.065% per day over the life of the 2026-05-15 option contract. With Stoke Therapeutics trading at USD 34.37, that is roughly USD 0.0223 . If you think that the market is fully incorporating Stoke Therapeutics' daily price movement you should consider acquiring Stoke Therapeutics options at the current volatility level of 1.04%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. Stoke Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Stoke Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Stoke Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Stoke Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Stoke Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Stoke Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Stoke Therapeutics' historical news coverage. Stoke Therapeutics' after-hype downside and upside margins for the prediction period are 30.40 and 38.88, respectively. We have considered Stoke Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Stoke Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Stoke Therapeutics is based on 3 months time horizon.
Stoke Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Stoke Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stoke Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Stoke Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 4.24 | 0.27 | 0.10 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
34.37 | 34.64 | 0.79 |
|
Stoke Therapeutics Hype Timeline
Stoke Therapeutics is at this time traded for 34.37. The entity has historical hype elasticity of 0.27, and average elasticity to hype of competition of -0.1. Stoke is estimated to increase in value after the next headline, with the price projected to jump to 34.64 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 0.79%, whereas the daily expected return is at this time at 0.3%. The volatility of related hype on Stoke Therapeutics is about 1333.33%, with the expected price after the next announcement by competition of 34.27. The company reported the previous year's revenue of 36.55 M. Net Loss for the year was (88.98 M) with profit before overhead, payroll, taxes, and interest of 205.63 M. Given the investment horizon of 90 days the next estimated press release will be in about 11 days. Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections.Stoke Therapeutics Related Hype Analysis
Having access to credible news sources related to Stoke Therapeutics' direct competition is more important than ever and may enhance your ability to predict Stoke Therapeutics' future price movements. Getting to know how Stoke Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Stoke Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NTLA | Intellia Therapeutics | 0.04 | 7 per month | 3.77 | 0.14 | 10.12 | (6.34) | 23.60 | |
| UPB | Upstream Bio | (0.06) | 9 per month | 0.00 | (0.13) | 7.84 | (12.87) | 57.85 | |
| ARDX | Ardelyx | 0.73 | 18 per month | 2.77 | 0.06 | 5.49 | (4.65) | 25.22 | |
| SYRE | Spyre Therapeutics | (1.02) | 8 per month | 2.37 | 0.21 | 7.15 | (4.47) | 20.03 | |
| WVE | Wave Life Sciences | (0.39) | 7 per month | 3.59 | 0.10 | 6.72 | (5.96) | 164.47 | |
| ZYME | Zymeworks Common Stock | 0.34 | 6 per month | 2.52 | 0.08 | 4.46 | (4.28) | 36.09 | |
| PHVS | Pharvaris BV | 0.16 | 7 per month | 3.36 | 0.06 | 5.82 | (5.72) | 27.81 | |
| NVAX | Novavax | (0.51) | 8 per month | 3.04 | 0.07 | 6.10 | (5.95) | 26.98 | |
| BCRX | BioCryst Pharmaceuticals | (0.20) | 8 per month | 2.47 | 0.03 | 4.46 | (4.19) | 16.75 | |
| ZBIO | Zenas BioPharma Common | (2.27) | 9 per month | 11.65 | 0.01 | 12.20 | (11.66) | 68.95 |
Stoke Therapeutics Additional Predictive Modules
Most predictive techniques to examine Stoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Stoke using various technical indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Stoke Therapeutics Predictive Indicators
The successful prediction of Stoke Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Stoke Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Stoke Therapeutics based on analysis of Stoke Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Stoke Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Stoke Therapeutics's related companies. | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.0469 | 0.043 | 0.0494 | Revenue Per Share | 0.2 | 0.68 | 0.61 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stoke Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 1.172 | Return On Assets | Return On Equity |
Investors evaluate Stoke Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Stoke Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Stoke Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Stoke Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.